| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
USA. MDMA therapy for PTSD rejected by FDA panel
USA. MDMA therapy for PTSD rejected by FDA panel
Scientific advisers vote overwhelmingly that the risks of MDMA treatment for post-traumatic stress disorder outweigh the benefits. (Nature, USA, 05.06.2024)